FDA Approval for Tisotumab Vedotin in Advanced Cervical Cancer FDA Approval for Tisotumab Vedotin in Advanced Cervical Cancer
Tisotumab vedotin-tftv (Tivdak), an antibody-drug conjugate, has been granted accelerated approval for the treatment of recurrent or metastatic cervical cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA grants accelerated approval to tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc.) for adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 21, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Uganda: Health Ministry to Introduce HPV Vaccine at 5 Years
[Independent (Kampala)] Kampala -- The Ministry of Health is planning to reduce the age at which girls get the Human Papilloma Vaccines which protects against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 20, 2021 Category: African Health Source Type: news

New Standard of Care in Cervical Cancer New Standard of Care in Cervical Cancer
The combination resulted in significant improvements in both progression-free and overall survival compared with chemotherapy (with or without bevacizumab) alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Impact of screening for sexual trauma in a gynecologic oncology setting - Gordinier ME, Shields LBE, Davis MH, Cagata S, Lorenz DJ.
OBJECTIVES: Sexual trauma poses a significant concern and is associated with heightened stress, negative health repercussions, and adverse economic effects. A history of abuse may increase a woman's risk of developing cancer, in particular cervical cancer.... (Source: SafetyLit)
Source: SafetyLit - September 15, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Zambia: Scaling Up Cervical Cancer Awareness Among Girls Vital
[Times of Zambia] As the COVID-19 pandemic and its vaccines take centre stage, concerns of the rising number of children who are missing routine vaccinations from last year have been observed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 13, 2021 Category: African Health Source Type: news

Earlier Elimination of Cervical Cancer Projected in Low - Poverty U.S. Counties
Increasing HPV vaccine coverage would reduce excess cancer cases, but it would not affect the time required to reach near - elimination (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 10, 2021 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, Pharmacy, Journal, Source Type: news

Consumer Health: 5 types of gynecologic cancer
September is Gynecologic Cancer Awareness Month, which makes this a good time to learn about the five types of gynecologic cancer. Gynecologic cancer is any cancer that starts in a woman's reproductive organs. More than 116,000 women in the U.S. will be diagnosed with a gynecologic cancer this year, according to the Foundation for Women's Cancer. The five main types of gynecologic cancer are: Cervical cancerEarly stage cervical cancer generally produces no signs or symptoms.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 6, 2021 Category: Databases & Libraries Source Type: news

Questions To Ask At Your First Cervical Cancer Screening
It's the job of your clinician to answer all of your questions and make you feel totally in control during your cervical cancer screening. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 31, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

How to prepare for a smear test: Can I request a female doctor for my smear test?
SMEAR tests are awkward and uncomfortable but essential to help prevent cancer and check for HPV. Here's how to prepare for your cervical screening. (Source: Daily Express - Health)
Source: Daily Express - Health - August 22, 2021 Category: Consumer Health News Source Type: news

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR p...
Source: Roche Media News - August 18, 2021 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR p...
Source: Roche Investor Update - August 18, 2021 Category: Pharmaceuticals Source Type: news

Sentinel Lymph Node in Cervical Cancer: Time To Move Forward Sentinel Lymph Node in Cervical Cancer: Time To Move Forward
Sentinel lymph node biopsy is shown to be a safe and effective alternative to pelvic lymph node dissection in cervical cancer. Is it time to consider it the gold-standard?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

What Is the First Stage of Cervical Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 12, 2021 Category: General Medicine Source Type: news

How to Sustainably Finance Universal Health Care
By Mary Suma Cardosa, Chan Chee Khoon, Chee Heng Leng and Jomo Kwame SundaramPENANG and KUALA LUMPUR, Aug 10 2021 (IPS) To achieve universal health coverage, a country needs a healthcare system that provides equitable access to high quality health care requiring sustainable financing over the long term. Publicly provided healthcare should be on the basis of need, a citizen’s entitlement for all regardless of means. Mary Suma CardosaHealth inequalities growing But recent decades have seen health care trending towards a two-tier system – a perceived higher quality private sector, and lower quality public service...
Source: IPS Inter Press Service - Health - August 10, 2021 Category: International Medicine & Public Health Authors: Mary Suma Cardosa - Chan Chee Khoon - Chee Heng Leng - Jomo Tags: Aid Economy & Trade Global Headlines Health Human Rights Inequity Sustainability TerraViva United Nations Source Type: news

Globally, Cervical Cancer Incidence, Mortality Stable or Decreasing
MONDAY, Aug. 9, 2021 -- Global cervical cancer incidence and mortality rates have remained stable or are decreasing, according to a study published online Aug. 9 in Cancer. Shujuan Lin, from Zhejiang University School of Medicine in Hangzhou,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 9, 2021 Category: Pharmaceuticals Source Type: news

Neuroimaging utilization in EDs increases by 72%
Overall emergency department (ED) neuroimaging use grew by 72% in the U.S. betwee...Read more on AuntMinnie.comRelated Reading: Emergency department CT use for cervical spine has increased LVO stroke patients benefit from going directly to angiography suite 'Redundant imaging' for TIA workup increases in the ED Decision support could improve ED pediatric appendicitis imaging Emergency visits present cancer screening opportunities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 4, 2021 Category: Radiology Source Type: news

Cancer Screenings Disrupted During Pandemic at Federally Qualified Health Centers
MONDAY, Aug. 2, 2021 -- The COVID-19 pandemic significantly disrupted breast, colorectal, and cervical cancer screenings among patients at federally qualified health centers (FQHCs), according to a study published online June 30 in Preventive... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 2, 2021 Category: Pharmaceuticals Source Type: news

American Society for Colposcopy and Cervical Pathology discusses updated American Cancer Society guidelines on cervical cancer screening
(Wolters Kluwer Health) Last year, the American Cancer Society (ACS) issued an updated set of guidelines for cervical cancer screening - emphasizing the shift toward screening with primary human papillomavirus (HPV) testing. While the ACS recommendation accounts for a transition period to implement primary HPV screening, additional factors should be considered to operationalize these guidelines, according to a special white paper in the July issue of the Journal of Lower Genital Tract Disease (JLGTD), official journal of ASCCP. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

From birth control to mammograms, many women missed out on preventive care for all of 2020
(Michigan Medicine - University of Michigan) The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind. The study looks at screenings for breast cancer, cervical cancer and sexually transmitted infections (STI), as well as two types of birth control care. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 16, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Obasanjo Advocates for National Policy to Eradicate Cervical Cancer in Nigeria
[Vanguard] Abeokuta -- Former President Olusegun Obasanjo on Wednesday advocated for a national policy for the eradication of cervical cancer in Nigeria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 15, 2021 Category: African Health Source Type: news

Perceived Financial Barriers Hinder Cervical Cancer Screening
72 percent of low - income, uninsured, or publicly insured women perceived financial barriers to screening (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 13, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Internal Medicine, Oncology, Pathology, Journal, Source Type: news

Perceived Financial Barriers Hinder Cervical Cancer Screening
TUESDAY, July 13, 2021 -- Nearly three in four low-income women cite perceived substantial financial barriers to undergoing cervical cancer screening, according to a study recently published in the Journal of Women's Health. Caitlin B. Biddell,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2021 Category: Pharmaceuticals Source Type: news

Be Clear on Cancer: first national'Cervical Screening Saves Lives' campaign
Evaluation of the first national'Cervical Screening Saves Lives'campaign which ran in 2019. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 12, 2021 Category: Consumer Health News Source Type: news

ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer
Dr Maurie Markman describes two large phase 3 trials that'clearly establish'the existing standard of care for cervical and ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Cost a Barrier to Cervical Cancer Screening for Many U.S. Women
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 2, 2021 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Preventive Medicine, News, Source Type: news

CDC Notes Sharp Declines in Breast and Cervical Cancer Screening CDC Notes Sharp Declines in Breast and Cervical Cancer Screening
Declines in breast and cervical cancer screening in the early months of the COVID-19 pandemic disproportionately affected racial and ethnic minority groups and rural populations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 2, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cost a Barrier to Cervical Cancer Screening for Many U.S. Women
FRIDAY, July 2, 2021 -- Many women in the United States aren't screened for cervical cancer because they can't afford it, a new study finds. Screening helps reduce cervical cancer cases and deaths, but disparities in screening rates exist based on... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 2, 2021 Category: General Medicine Source Type: news

Women's use of preventive health services during COVID-19
(JAMA Network)What The Study Did:Changes in the use of women's preventive health services during the COVID-19 pandemic, including screening for sexually transmitted infections, breast and cervical cancer, and obtaining contraceptives from pharmacies are described by researchers in this study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 2, 2021 Category: International Medicine & Public Health Source Type: news

Women's Cancer Screenings Plummeted During Pandemic
THURSDAY, July 1, 2021 -- Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic, according to a study published online June 30 in Preventive Medicine. Compared with the previous five-year... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2021 Category: Pharmaceuticals Source Type: news

Breast and cervical cancer screenings plunged by more than 80% during lockdowns in spring 2020
Many women avoided or delayed cancer screenings in spring 2020. Breast cancer screenings declined by 87% and cervical cancer screenings declined by 84%, compared to past years. (Source: the Mail online | Health)
Source: the Mail online | Health - July 1, 2021 Category: Consumer Health News Source Type: news

Women's Cancer Screenings Plummeted During Pandemic
WEDNESDAY, June 30, 2021 -- Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention says. That could lead to delayed cancer diagnoses,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 30, 2021 Category: General Medicine Source Type: news

MD Anderson research highlights for June 30, 2021
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include expanded use of a targeted therapy for a new group of patients with leukemia, molecular studies yielding novel cancer therapeutic targets, insights into radiation therapy resistance and a community intervention to reduce cervical cancer rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news

Financial barriers to cervical cancer screening
(Mary Ann Liebert, Inc./Genetic Engineering News) Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening. The most commonly reported barriers were screening appointment costs (71%) and follow-up/future treatment costs (44%). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Woman dies after Scottish cancer screening error
About 430 women have been incorrectly excluded from Scotland's cervical screening programme. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 24, 2021 Category: Consumer Health News Source Type: news

ASCO Study Shows Cervical Cancer Cases Have Declined by More than 1% Per Year Over the Past 16 Years, Likely Due to HPV Screening and Vaccine
Some experts question the usefulness of Pap testing going forward. But how would cutting back on Pap testing affect clinical laboratory revenue and is it safe for cancer patients? Recently, a major medical society issued its findings that cervical cancer in the United States has been on a sustained decline for more than a decade […] The post ASCO Study Shows Cervical Cancer Cases Have Declined by More than 1% Per Year Over the Past 16 Years, Likely Due to HPV Screening and Vaccine appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - June 16, 2021 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Pathology and Clinical Laboratory Conferences American Society of Clinical Oncology anatomic pathology ASCO Baylor University Medical Center cance Source Type: news

Many Older Women Not Eligible to Quit Cervical Cancer Screening
Findings consistent among women with employer - based insurance and those treated at a safety net health center (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 15, 2021 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Oncology, Pathology, Journal, Source Type: news

Many Older Women Not Eligible to Quit Cervical Cancer Screening
TUESDAY, June 15, 2021 -- About two-thirds of older women fail to qualify for discontinuation of cervical cancer screening, according to a study published online June 3 in Gynecologic Oncology. Jacqueline M. Mills, M.D., from the Boston University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2021 Category: Pharmaceuticals Source Type: news

Nigeria: First Ladies Lament Setback in Anti-Cervical Cancer Campaign
[This Day] The Nigeria's target to achieve cervical cancer elimination by 2030 as prescribed by the World Health Organisation (WHO), may no longer be feasible. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 15, 2021 Category: African Health Source Type: news

Kenya: The Fight Against Cervical Cancer Is Very Much a Man's Issue
[Nation] I have a friend called Kami. She's been my friend since I was six. That's over a quarter-century of friendship. She prefers to be called by her full name, Mukami, but she makes an exception with me because we've known each other for most of our lives and it's late for me to change her pet name. I know her mother and I can still report Kami to her years later. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 12, 2021 Category: African Health Source Type: news

Drug commonly used as antidepressant helps fight cancer in mice
A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain ’s “happiness hormone.”A new study by UCLA researchers suggests that those drugs, commonly known as MAOIs, might have another health benefit: helping the immune system attack cancer. Their findings are reported in two papers, which are published in the journals Science Immunology and Nature Communications.“MAOIs had not been linked to the immune system’s response to cancer before,” saidLili Yang, senior author of the study and a m...
Source: UCLA Newsroom: Health Sciences - June 10, 2021 Category: Universities & Medical Training Source Type: news

Rwanda: American Medics Partner With Rwandan Counterparts in Fighting Cervical Cancer
[New Times] A team of 13 doctors and volunteers from the United States was in Rwanda for a week on a mission to equip doctors, mainly from the University of Rwanda with skills to treat cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 8, 2021 Category: African Health Source Type: news

Two-thirds of women don't meet criteria to discontinue cervical cancer screening
(Boston Medical Center) Current guidelines recommend stopping cervical cancer screening at age 65, but women over age 65 make up over one in five new cervical cancer diagnoses, and are twice as likely to die after a cervical cancer diagnosis compared to younger women. New research from Boston Medical Center found that fewer than one in three women aged 64 to 66 met the criteria to discontinue cervical cancer screening while looking at patients with both private insurance and from a safety-net hospital setting. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 7, 2021 Category: Biology Source Type: news

Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo
Adjuvant chemotherapy did not improve survival and was associated with significantly higher toxicity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO: Incidence of Cervical Cancer Has Decreased in the United States
TUESDAY, June 1, 2021 -- The incidence of cervical cancer has decreased, while the incidence of other human papillomavirus (HPV)-related cancers has increased in the United States, according to a study scheduled to be presented at the annual meeting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2021 Category: Pharmaceuticals Source Type: news

VC firm seeking $50M to invest in women ’s health technology
A new venture capital firm formed to invest in women ’s health technology is seeking to raise $50 million for its funding pool. The company, FemHealth Ventures, said it plans to make 15 investments from the fund. Maneesha Ghiya and partner Noraan Sadik formed Short Hills, New Jersey-based FemHealth Ventures in August of 2020 to fund companies tar geting treatments and cures for conditions appearing only in women, like endometriosis, polycystic ovarian syndrome and cervical cancer; mostly in women,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 30, 2021 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

VC firm seeking $50M to invest in women ’s health technology
A new venture capital firm formed to invest in women ’s health technology is seeking to raise $50 million for its funding pool. The company, FemHealth Ventures, said it plans to make 15 investments from the fund. Maneesha Ghiya and partner Noraan Sadik formed Short Hills, New Jersey-based FemHealth Ventures in August of 2020 to fund companies tar geting treatments and cures for conditions appearing only in women, like endometriosis, polycystic ovarian syndrome and cervical cancer; mostly in women,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 30, 2021 Category: Biotechnology Authors: Anne Stych Source Type: news

To Beat Covid, Beat HIV, & Beat Inequality, Find the Money
A woman is vaccinated against COVID-19 in the indigenous community of Concordia, Colombia. Meanwhile, UN Secretary-General Antonio Guterres repeated his call for the G20 to establish a Task Force “able to deal with the pharmaceutical companies and other key stakeholders”, which would address equitable vaccine distribution through the COVAX global initiative. Credit: WHO/Nadege MazarsBy Winnie ByanyimaGENEVA, May 27 2021 (IPS) In this time of intersecting crises – the Covid crisis, the HIV crisis, the inequality crisis, and more – progress on all these crises is being blocked by another crisis: finan...
Source: IPS Inter Press Service - Health - May 27, 2021 Category: International Medicine & Public Health Authors: Winnie Byanyima Tags: Aid Development & Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies Population Poverty & SDGs TerraViva United Nations Source Type: news

New Era for Cervical Cancer With Cemiplimab'Impressive' Results New Era for Cervical Cancer With Cemiplimab'Impressive' Results
The superiority of cemiplimab over chemotherapy in improving overall survival in patients with recurrent or metastatic cervical cancer was hailed as"practice changing."Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news